Opexa Therapeutics, Inc. (OPXA) Reports Q1 Loss of $0.13
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q1 EPS of ($0.13), versus ($0.58) reported last year. Revenue for the quarter came in at $348.8 thousand, versus $220.1 thousand reported last year.
For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
- Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
